Home
NewsNewsProtein injection repairs aged eggs by restoring chromosome stability, helping improve IVF success rates for older mothers, according to new fertility research that offers a promising clinical advancement for reproductive health.
A laboratory technique showing that protein injection repairs aged eggs may offer a new way to improve IVF outcomes for older women, according to findings shared by researchers in Europe.
The work was carried out by a research team led by Dr. Melina Schuh at the Max Planck Institute for Multidisciplinary Sciences in Germany. Dr. Melina Schuh, who is also a co-founder of Ovo Labs, presented the data at the British Fertility Society Conference in Scotland. The study was released simultaneously on the preprint platform bioRxiv.
Fertility decreases rapidly with age because eggs created before birth have to lie dormant for years before being ovulated. While IVF is still moderately effective for women under age 35, success rates plummet after age 40 because eggs fail to evenly divide their chromosomes during meiosis. Mistakes during meiosis can lead to embryos with missing or extra chromosomes, causing IVF failure.
To improve fertility, the researchers targeted shugoshin1, a protein that keeps pairs of chromosomes glued together during egg development. Shugoshin1 levels decrease with age, weakening chromosomes' connection. The researchers experimented with restoring shugoshin1 to see if it would lessen defects.
Researchers microinjected shugoshin1 into mouse and donated human eggs. Microinjection resulted in a decrease in early chromosome separation. Human eggs experienced a decrease in chromosome defects from 53% to 29%. When looking specifically at eggs from women over 35, chromosome defects decreased from 65% to 44%. These findings suggest that protein injection repairs aged eggs by stabilising chromosome behaviour during division.
Currently, intracytoplasmic sperm injection (ICSI) is the only widely used microinjection method in fertility clinics. The researchers say the approach uses comparable techniques and are discussing possible clinical trials with regulators.
Commenting on the findings, Professor Guzel Taylor of the University of Edinburgh said the work was “a very promising result,” adding, “Since most women start IVF with already aged eggs, this technology is highly significant.”
Further studies are planned to assess safety and effectiveness before the method can be tested in clinical IVF settings
Fertility care leader IVI RMA North America announces a new partnership with Island Reproductive Services
Overture Life’s DaVitri fertility automation platform gains CE Mark, paving the way for wider IVF and egg freezing access in Europe.
Simbryo Technologies introduces the Simbryo FX personalized assay, a diagnostic test that measures endometrial fertility to predict embryo implantation success and improve IVF outcomes with more than 90% specificity.
Technology-Enabled Cryostorage is transforming fertility storage as Reprotech and TMRW combine expertise in digital specimen management and biorepository services. The partnership enhances scalability, safety, and efficiency while supporting clinics with advanced solutions. This strategic move positions the combined company to lead innovation and meet growing global demand in cryostorage services.
CDSCO Orders on IVF Medical Devices reinforce strict regulatory oversight across India’s fertility sector. The directive mandates licensing compliance under existing laws, ensuring IVF and ART devices meet safety and quality standards. This move aims to curb unauthorized sales, strengthen enforcement, and bring greater accountability to medical device usage in reproductive healthcare.
The Tennessee State Law could change how the embryos are handled at the time of treatment, thereby making the IVF clinic services in the state more expensive for patients seeking fertility care.
Before taking a call on IVF, survey conducted in the U.S., UK, Ireland, and Canada suggests that people are looking for complete & less expensive options to treat root causes of infertility.
